Medical Device News Magazine

Endoluxe Enters Into Multi-year USA Distribution Agreement With Dornier MedTech for Urology Segment

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Endoluxe announced that they have entered into a multi-year exclusive distribution agreement specifically for the urology market with Dornier MedTech. Dornier and Endoluxe have products and platforms focused in the urology arena offering innovation and value.

“We are absolutely ecstatic to partner with Dornier MedTech to address the growing demands for better imaging solutions in urology,” states CEO Devon Bream. “Coming out of the American Urology Association (AUA) conference last month, we knew from the amount of exhibit buzz around Endoluxe that the time was right to select a market leading partner to help us grow our existing urology business. Dornier MedTech is an excellent partner to work with and we appreciate their support of our platform.”

The Endoluxe EVS is the perfect camera system for all endoscopic procedures that utilize industry standard rigid and flexible analogue scopes such as urology, gynecology, ENT, general surgery, and orthopedics. The handheld Orb replaces the legacy endoscopic tower with advanced, portable technology at 1/6 the cost. Specifically for urology, the Endoluxe Orb has a novel image stabilization functionality that benefits urologists during basic and complex urologic procedures.

“We are pleased to add the Endoluxe platform to our growing portfolio as we believe their technology represents the future of endoscopic visualization. With the various new urology products that Dornier introduced at AUA, it is an ideal situation to have Endoluxe join our portfolio of market leading urology products,” states Brock Faulkner, CEO of Dornier MedTech America.

Endoluxe is a world-class endoscopic video imaging organization based in the United States with worldwide distribution of its medical industry design award-winning Endoluxe Orb. The company is focused on reducing costs of legacy video platforms, enhancing procedure adoption, and improving patient outcomes through better therapy application. Endoluxe is committed to being a vendor agnostic platform that allows customers to utilize their existing investment in traditional scopes and supporting devices, while taking advantage of future technological advancements utilizing our portable, integrated, and feature-laden platform at 1/6th the cost of legacy products.

Dornier MedTech is a medical device company headquartered in Munich, Germany, and is a full subsidiary of Advanced MedTech. As a pioneer in the field of urology, Dornier is one of the most trusted names in the industry. The company continues to drive clinical performance and spearhead innovation in urology, launching several pioneering technologies and revolutionary therapies in recent years.

As the world’s first MDR-certified integrated urology company, and one of the original founders of the Urology Care Foundation (formerly known as the American Foundation for Urologic Diseases), Dornier takes pride in holding to the highest standards of patient safety and product efficacy. Today, the company is pushing the envelope in digital urology to provide holistic care to patients seeking treatment and community support in their recovery journey through online and in-person channels. Trusted by thousands of physicians and patients, Dornier is committed to serving and supporting the urology community worldwide.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”